Opportunity Information: Apply for CDC RFA GH14 1405
Apply for CDC RFA GH14 1405
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Public Health Capacity in Bangladesh" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Jan 7, 2014 and posted on Jan 7, 2014.
- Applicants must submit their applications by Apr 1, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $30,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below Non domestic (non U.S.) entity Eligibility for this FOA is limited due to the requirements considered necessary to carry out the key objectives and activities of the FOA which conducting surveillance, outbreak response and laboratory diagnostics on diseases of public health importance in Bangladesh. The program will be required to carry out multiple surveillance platforms and other public health strengthening activities including mentoring and training junior scientists at the same time. In order to achieve the expected results of the FOA the following are considered necessary A certified biosafety level three (BSL 3) laboratory in Bangladesh that is uniquely equipped to perform research and diagnostic testing on samples from surveillance of human and animal populations that are suspected of being highly pathogenic (Nipah virus, avian influenza or unknown pathogens), as well as provide laboratory support to the Ministry of Health and Family Welfare (MOHFW) in Bangladesh. Have the legal authority to hire third country nationals with the technical skills to meet the requirements of the proposed surveillance and outbreak response components in an efficient and timely manner. Have the legal authority to process supplies, including temperature sensitive reagents, through the customs process in an efficient, cost effective and timely manner to ensure their viability upon receipt.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Strengthening Public Health Capacity in Bangladesh" is a CDC cooperative agreement designed to expand and modernize Bangladesh's ability to detect, investigate, and control infectious diseases that pose major public health risks. The core focus is building stronger public health surveillance and epidemiology systems, improving laboratory and diagnostic capacity, and supporting the implementation of evidence-based disease prevention and control programs. While the scope includes infectious diseases broadly, the opportunity highlights priority areas such as zoonotic diseases, tuberculosis, influenza, and other high-consequence threats, including pathogens with pandemic potential.
A central aim of the program is to strengthen end-to-end disease detection and response: from collecting reliable surveillance data in communities and health facilities, to performing high-quality laboratory testing, to using epidemiological methods to interpret trends and guide interventions. Activities envisioned under the award include conducting epidemiological assessments, developing or improving surveillance platforms that monitor human and animal populations, and ensuring that laboratory systems can safely and accurately test for high-risk pathogens. The opportunity places clear emphasis on operational readiness for outbreaks, meaning recipients should be able to support rapid investigation and response when unusual events occur, and to translate findings into actionable control measures at local, district, and national levels.
Workforce development is another major pillar. The program calls for training scientists, laboratorians, health professionals, and fellows or students in practical public health skills such as health assessment, surveillance design, field epidemiology, outbreak investigation, data collection, data management, and statistical analysis. It also stresses evidence-based program planning, implementation, and evaluation, so that public health interventions are not only launched, but also assessed for effectiveness and continuously improved. In practice, this means the award supports both immediate capacity (for example, mentoring staff who run surveillance sites or labs) and longer-term institutional capability (for example, developing a cadre of professionals who can lead national disease control initiatives).
The grant also emphasizes strengthening public health systems through learning and collaboration. Applicants are expected to incorporate lessons learned from evaluations and assessments of disease control and eradication efforts in Bangladesh, using those findings to refine strategy and improve outcomes. Beyond Bangladesh, the program seeks sharing of expertise with public health partners in the region, reflecting the reality that infectious disease threats often cross borders and require coordination. This regional approach aligns with the broader goal of advancing global health security.
Biosafety and biosecurity are explicitly included as priorities, with the intent of reducing the risk of accidental or deliberate spread of dangerous pathogens and preventing diseases from moving across borders. This component complements the laboratory and surveillance objectives, acknowledging that stronger detection capacity must be matched by safe handling, containment practices, and secure systems for high-risk specimens and pathogens.
From an administrative standpoint, this is a discretionary funding opportunity using a cooperative agreement mechanism, which typically means CDC expects substantial involvement through technical guidance, collaboration, and program oversight rather than simply issuing funds with minimal engagement. The funding opportunity number is CDC RFA GH14-1405, with CFDA 93.283 (CDC Investigations and Technical Assistance). The total estimated funding was $30,000,000, with an award ceiling of $5,000,000 and no stated minimum award floor. The announcement anticipated up to 10 awards, did not require cost sharing or matching, and was posted January 7, 2014, with an application closing date of April 1, 2014 (now archived as of May 1, 2014).
Eligibility was limited and tailored to the operational demands of the work in Bangladesh. The CDC restricted eligibility to non-U.S. (non-domestic) entities and specified capabilities considered essential to meeting the objectives. In particular, applicants needed access to a certified biosafety level 3 (BSL-3) laboratory in Bangladesh equipped to handle and test specimens suspected of containing highly pathogenic agents such as Nipah virus, avian influenza, or unknown pathogens, and able to provide laboratory support to the Ministry of Health and Family Welfare. The opportunity also required that the applicant have the legal authority to hire third-country nationals with specialized technical skills to support surveillance and outbreak response, and the legal authority to import and clear supplies through customs efficiently, including temperature-sensitive reagents that can be ruined by delays. These requirements reflect the practical realities of sustaining high-functioning surveillance and laboratory systems where rapid staffing and reliable supply chains can determine whether an outbreak is contained early or grows unchecked.
Overall, the opportunity is best understood as a comprehensive capacity-building effort that links surveillance, laboratory diagnostics, workforce training, outbreak response, and continuous improvement through evaluation, all under a global health security frame. Its intent is to leave Bangladesh better equipped to identify infectious threats quickly, confirm them safely and accurately, analyze and interpret data to guide action, and implement effective public health programs that protect communities while contributing to regional and global disease prevention efforts.
Frequently Asked Questions (FAQs): Strengthening Public Health Capacity in Bangladesh (CDC RFA GH14-1405)
What is the "Strengthening Public Health Capacity in Bangladesh" grant opportunity?
It is a CDC discretionary funding opportunity offered as a cooperative agreement to expand and modernize Bangladesh's ability to detect, investigate, and control infectious diseases that pose major public health risks. The program is framed as a comprehensive capacity-building effort that links surveillance, laboratory diagnostics, workforce development, outbreak response, and continuous improvement through evaluation.
What is the main goal of this cooperative agreement?
The central goal is to strengthen end-to-end disease detection and response in Bangladesh, including reliable surveillance data collection, high-quality laboratory testing, and epidemiologic analysis that guides evidence-based disease prevention and control actions at local, district, and national levels.
What are the core focus areas supported by this opportunity?
The opportunity focuses on (1) strengthening public health surveillance and epidemiology systems, (2) improving laboratory and diagnostic capacity, and (3) supporting implementation of evidence-based disease prevention and control programs.
Which diseases or threats are prioritized in the announcement?
While the scope includes infectious diseases broadly, the announcement highlights zoonotic diseases, tuberculosis, influenza, and other high-consequence threats, including pathogens with pandemic potential.
What does "end-to-end disease detection and response" mean in this opportunity?
It refers to a full pathway of readiness and capability: collecting surveillance data from communities and health facilities, conducting safe and accurate laboratory diagnostics (including for high-risk pathogens), applying epidemiological methods to interpret trends, and translating findings into actionable control measures.
What types of surveillance activities are envisioned?
Activities include conducting epidemiological assessments and developing or improving surveillance platforms that monitor human and animal populations, reflecting the emphasis on zoonotic and other cross-cutting infectious threats.
What laboratory capacity improvements does the opportunity emphasize?
The opportunity emphasizes laboratory systems that can safely and accurately test for high-risk pathogens, with explicit attention to biosafety and biosecurity as part of strengthening detection capacity.
How does the opportunity address outbreak investigation and response readiness?
It places clear emphasis on operational readiness for outbreaks, meaning recipients should be able to support rapid investigation and response when unusual events occur and use findings to guide control measures across different administrative levels.
What workforce development and training activities are supported?
The award supports training for scientists, laboratorians, health professionals, and fellows or students in practical public health skills such as health assessment, surveillance design, field epidemiology, outbreak investigation, data collection, data management, and statistical analysis.
Does the opportunity include program planning and evaluation?
Yes. It stresses evidence-based program planning, implementation, and evaluation so public health interventions are assessed for effectiveness and continuously improved, not just launched.
How are "lessons learned" expected to be used under this award?
Applicants are expected to incorporate lessons learned from evaluations and assessments of disease control and eradication efforts in Bangladesh, using those findings to refine strategies and improve outcomes.
Does the program involve collaboration beyond Bangladesh?
Yes. In addition to strengthening Bangladesh's systems, the opportunity calls for sharing expertise with public health partners in the region, recognizing that infectious disease threats cross borders and require coordination.
Why are biosafety and biosecurity included as explicit priorities?
They are included to reduce the risk of accidental or deliberate spread of dangerous pathogens and to help prevent diseases from moving across borders, complementing surveillance and laboratory objectives with safe handling and secure systems.
What kind of funding mechanism is used for this opportunity?
The opportunity uses a cooperative agreement mechanism, meaning CDC expects substantial involvement through technical guidance, collaboration, and program oversight rather than providing funds with minimal engagement.
What is the funding opportunity number and CFDA listing for this grant?
The funding opportunity number is CDC RFA GH14-1405. The CFDA is 93.283, listed as CDC Investigations and Technical Assistance.
How much funding was estimated to be available under the announcement?
The total estimated funding was $30,000,000.
What was the maximum award amount per recipient?
The award ceiling was $5,000,000.
Was a minimum award amount specified?
No minimum award floor was stated in the provided information.
How many awards were anticipated?
The announcement anticipated up to 10 awards.
Was cost sharing or matching required?
No. The announcement did not require cost sharing or matching.
When was the opportunity posted and when did applications close?
It was posted on January 7, 2014, and the application closing date was April 1, 2014.
Is this funding opportunity still open?
No. It is archived as of May 1, 2014.
Who was eligible to apply?
Eligibility was limited to non-U.S. (non-domestic) entities and was tailored to the operational demands of carrying out the work in Bangladesh.
What specific laboratory access was required for eligibility?
Applicants needed access to a certified biosafety level 3 (BSL-3) laboratory in Bangladesh capable of handling and testing specimens suspected of containing highly pathogenic agents such as Nipah virus, avian influenza, or unknown pathogens, and able to provide laboratory support to the Ministry of Health and Family Welfare.
Why did the opportunity require access to a certified BSL-3 laboratory in Bangladesh?
Because the program emphasizes safe and accurate testing for high-risk pathogens and operational readiness for outbreaks, including pathogens with pandemic potential. A certified BSL-3 laboratory is part of ensuring biosafety, biosecurity, and reliable diagnostic capability in-country.
What staffing-related legal authority was required?
The applicant needed the legal authority to hire third-country nationals with specialized technical skills to support surveillance and outbreak response.
What supply chain and customs-related legal authority was required?
The applicant needed the legal authority to import and clear supplies through customs efficiently, including temperature-sensitive reagents that can be ruined by delays.
Why are hiring authority and customs clearance emphasized in the eligibility requirements?
These requirements reflect practical realities of sustaining high-functioning surveillance and laboratory systems, where rapid staffing and reliable importation of critical, temperature-sensitive materials can determine whether an outbreak is contained early.
How does this opportunity support Bangladesh's Ministry of Health and Family Welfare?
The eligibility requirements explicitly reference providing laboratory support to the Ministry of Health and Family Welfare, and the program scope centers on strengthening national capacity for surveillance, diagnostics, and outbreak response.
What is the broader public health rationale behind this opportunity?
The opportunity is positioned within a global health security frame, aiming to leave Bangladesh better equipped to identify infectious threats quickly, confirm them safely and accurately, interpret data to guide action, and implement effective public health programs that protect communities and contribute to regional and global disease prevention efforts.
Browse more opportunities from the same category: Health
Next opportunity: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
Previous opportunity: Research Using Subjects From Selected Type I Diabetes Clinical Studies (Living Biobank) (DP3)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH14 1405
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH14 1405) also looked into and applied for these:
| Funding Opportunity |
|---|
| Saving Lives at Birth A Grand Challenge for Development (Round 4) Apply for RFA OAA 14 000071 Funding Number: RFA OAA 14 000071 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Cincinnati, Ohio Apply for HRSA 14 115 Funding Number: HRSA 14 115 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition Specific pathogen free macaque colonies (U42) Apply for PAR 14 066 Funding Number: PAR 14 066 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Traumatic Brain Injury State Implementation Partnership Grant Program Apply for HRSA 14 019 Funding Number: HRSA 14 019 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| System level Workforce Capacity Building for Integrating HIV Primary Care in Community Health Care Settings Demonstration Sites Apply for HRSA 14 055 Funding Number: HRSA 14 055 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| System level Workforce Capacity Building for Integrating HIV Primary Care in Community Healthcare Settings Evaluation and Technical Assistance Center Cooperative Agreement Apply for HRSA 14 058 Funding Number: HRSA 14 058 Agency: Health Resources and Services Administration Category: Health Funding Amount: $550,000 |
| Neurobiology of Migraine (R01) Apply for PA 14 068 Funding Number: PA 14 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neurobiology of Migraine (R21) Apply for PA 14 069 Funding Number: PA 14 069 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121003CONT14 Funding Number: CDC RFA DP12 121003CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIA Limited Competition Renewal of, and Revisions to, the Alzheimers Disease Genetics Consortium (U01) Apply for PAR 14 070 Funding Number: PAR 14 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Early Intervention Services (EIS Program) Existing Geographic Service Areas (EISEGA) Apply for HRSA 14 117 Funding Number: HRSA 14 117 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Resource and Technical Assistance Center for HIV Prevention and Care for Black Men who Have Sex with Men (Black MSM) Cooperative Agreement Apply for HRSA 14 106 Funding Number: HRSA 14 106 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,500,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 14 073 Funding Number: PAR 14 073 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition to Develop a BrainSpan RNA seq Browser (R24) Apply for RFA MH 15 100 Funding Number: RFA MH 15 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) Apply for RFA AG 15 002 Funding Number: RFA AG 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimers Disease Core Centers (P30) Apply for RFA AG 15 001 Funding Number: RFA AG 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Poison Center Support and Enhancement Apply for HRSA 14 016 Funding Number: HRSA 14 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Supporting Healthy Start Performance Project Apply for HRSA 14 042 Funding Number: HRSA 14 042 Agency: Health Resources and Services Administration Category: Health Funding Amount: $2,000,000 |
| Service Area Competition Additional Area (SAC AA) DC, FL, GA, ID, IL, KS, MO, MT, NY, OR, PA Apply for HRSA 14 116 Funding Number: HRSA 14 116 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research Apply for RFA GH 14 003 Funding Number: RFA GH 14 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH14 1405", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.